Tarek Mazzawi Selected Research

Diarrhea

9/2022	The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study.
6/2022	Gut Microbiota Manipulation in Irritable Bowel Syndrome.
1/2021	The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
1/2020	Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation.
6/2019	Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
1/2017	Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tarek Mazzawi Research Topics

Disease

13	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 09/2022 - 11/2014
6	Diarrhea 09/2022 - 01/2017
3	Dysbiosis 09/2022 - 05/2018
1	Celiac Disease (Celiac Sprue) 06/2023
1	Adenocarcinoma 06/2020
1	Dyspepsia (Indigestion) 01/2019
1	Flatulence 09/2017
1	Abdominal Pain (Pain, Abdominal) 09/2017
1	Body Weight (Weight, Body) 09/2017
1	Pain (Aches) 01/2017
1	Colitis 12/2016
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2013

Drug/Important Bio-Agent (IBA)

3	Chromogranin AIBA 05/2016 - 11/2014
2	16S Ribosomal RNAIBA 09/2022 - 01/2022
1	Glutens (Glutelin)IBA 06/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	Rifaximin (L 105)FDA Link 06/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	uroguanylinIBA 01/2020
1	Volatile Fatty AcidsIBA 06/2019
1	AntralIBA 01/2019
1	OligosaccharidesIBA 09/2017
1	Dietary Fiber FDA Link 09/2017
1	CholesterolIBA 09/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2016
1	Peptide YYIBA 02/2013

Therapy/Procedure

9	Fecal Microbiota Transplantation 09/2022 - 01/2018
1	Transplantation 09/2022
1	Chemoradiotherapy 06/2020
1	Radiofrequency Ablation 06/2020
1	Glycemic Control 09/2017